4li5: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
m Protected "4li5" [edit=sysop:move=sysop]
OCA (talk | contribs)
No edit summary
Line 5: Line 5:
Authors: Debreczeni, J.E., Seiffert, G.B., Kiefersauer, R., Augustin, M., Nagel, S., Ward, R., Anderton, M., Ashton, S., Bethel, P., Box, M., Butterworth, S., Colclough, N., Chroley, C., Chuaqui, C., Cross, D., Eberlein, C., Finlay, R., Hill, G., Grist, M., Klinowska, T., Lane, C., Martin, S., Orme, J., Smith, P., Wang, F., Waring, M.
Authors: Debreczeni, J.E., Seiffert, G.B., Kiefersauer, R., Augustin, M., Nagel, S., Ward, R., Anderton, M., Ashton, S., Bethel, P., Box, M., Butterworth, S., Colclough, N., Chroley, C., Chuaqui, C., Cross, D., Eberlein, C., Finlay, R., Hill, G., Grist, M., Klinowska, T., Lane, C., Martin, S., Orme, J., Smith, P., Wang, F., Waring, M.


Description: EGFR-K IN COMPLEX WITH N-[3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-4-methoxy-phenyl] prop-2-enamide
Description: EGFR-K IN COMPLEX WITH N-[3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-4-methoxy-phenyl] Prop-2-enamide